Exscientia Analyst Ratings
Exscientia Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/17/2023 | 72.41% | Barclays | $12 → $10 | Maintains | Overweight |
| 10/11/2023 | 20.69% | Morgan Stanley | $14 → $7 | Maintains | Equal-Weight |
| 08/01/2023 | 141.38% | Morgan Stanley | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight |
| 07/31/2023 | 141.38% | Morgan Stanley | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight |
| 07/24/2023 | 141.38% | Morgan Stanley | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight |
| 07/21/2023 | 124.14% | Berenberg | → $13 | Initiates Coverage On | → Buy |
| 07/20/2023 | 141.38% | Morgan Stanley | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight |
| 07/17/2023 | 141.38% | Morgan Stanley | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight |
| 06/26/2023 | 141.38% | Morgan Stanley | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight |
| 06/20/2023 | 141.38% | Morgan Stanley | → $14 | Reiterates | → Equal-Weight |
| 06/12/2023 | 141.38% | Morgan Stanley | → $14 | Reiterates | → Equal-Weight |
| 04/10/2023 | 141.38% | Morgan Stanley | $15 → $14 | Maintains | Equal-Weight |
| 11/16/2022 | 106.9% | Barclays | $40 → $12 | Maintains | Overweight |
| 09/09/2022 | 158.62% | Morgan Stanley | $18 → $15 | Maintains | Equal-Weight |
| 08/24/2022 | 210.34% | Morgan Stanley | $20 → $18 | Maintains | Equal-Weight |
| 06/13/2022 | 244.83% | Morgan Stanley | $21 → $20 | Maintains | Equal-Weight |
| 05/24/2022 | 244.83% | Goldman Sachs | $23 → $20 | Maintains | Buy |
| 04/11/2022 | 262.07% | Morgan Stanley | $20 → $21 | Maintains | Equal-Weight |
| 10/26/2021 | 365.52% | B of A Securities | → $27 | Initiates Coverage On | → Buy |
| 10/26/2021 | 331.03% | Morgan Stanley | → $25 | Initiates Coverage On | → Equal-Weight |
| 10/26/2021 | 417.24% | Goldman Sachs | → $30 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 10/17/2023 | 72.41% | 巴克萊 | $12→$10 | 維護 | 超重 |
| 2023年10月11日 | 20.69% | 摩根士丹利 | $14→$7 | 維護 | 等重 |
| 08/01/2023 | 141.38% | 摩根士丹利 | $14→$14 | 重申 | 等重→等重 |
| 07/31/2023 | 141.38% | 摩根士丹利 | $14→$14 | 重申 | 等重→等重 |
| 07/24/2023 | 141.38% | 摩根士丹利 | $14→$14 | 重申 | 等重→等重 |
| 07/21/2023 | 124.14% | 貝倫伯格 | →$13 | 開始承保 | →購買 |
| 07/20/2023 | 141.38% | 摩根士丹利 | $14→$14 | 重申 | 等重→等重 |
| 07/17/2023 | 141.38% | 摩根士丹利 | $14→$14 | 重申 | 等重→等重 |
| 2023/06/26 | 141.38% | 摩根士丹利 | $14→$14 | 重申 | 等重→等重 |
| 06/20/2023 | 141.38% | 摩根士丹利 | →$14 | 重申 | →等重 |
| 2023/06/12 | 141.38% | 摩根士丹利 | →$14 | 重申 | →等重 |
| 04/10/2023 | 141.38% | 摩根士丹利 | $15→$14 | 維護 | 等重 |
| 2022年11月16日 | 106.9% | 巴克萊 | $40→$12 | 維護 | 超重 |
| 09/09/2022 | 158.62% | 摩根士丹利 | $18→$15 | 維護 | 等重 |
| 2022年08月24日 | 210.34% | 摩根士丹利 | $20→$18 | 維護 | 等重 |
| 2022/06/13 | 244.83% | 摩根士丹利 | $21→$20 | 維護 | 等重 |
| 2022年05月24日 | 244.83% | 高盛 | $23→$20 | 維護 | 買 |
| 04/11/2022 | 262.07% | 摩根士丹利 | $20→$21 | 維護 | 等重 |
| 10/26/2021 | 365.52% | B of A證券 | →$27 | 開始承保 | →購買 |
| 10/26/2021 | 331.03% | 摩根士丹利 | →$25 | 開始承保 | →等重 |
| 10/26/2021 | 417.24% | 高盛 | →$30 | 開始承保 | →購買 |
What is the target price for Exscientia (EXAI)?
ExScience a(EXAI)的目標價是多少？
The latest price target for Exscientia (NASDAQ: EXAI) was reported by Barclays on October 17, 2023. The analyst firm set a price target for $10.00 expecting EXAI to rise to within 12 months (a possible 72.41% upside). 13 analyst firms have reported ratings in the last year.
巴克萊銀行於2023年10月17日報道了ExScience a(納斯達克：EXAI)的最新目標價。這家分析公司將目標價定為10.00美元，預計EXAI將在12個月內上漲至72.41%。過去一年，有13家分析公司公佈了評級。
What is the most recent analyst rating for Exscientia (EXAI)?
ExScience a(EXAI)的最新分析師評級是多少？
The latest analyst rating for Exscientia (NASDAQ: EXAI) was provided by Barclays, and Exscientia maintained their overweight rating.
巴克萊銀行提供了最新的分析師對ExScience a公司(納斯達克股票代碼：EXAI)的評級，該公司維持其增持評級。
When is the next analyst rating going to be posted or updated for Exscientia (EXAI)?
ExScience a(EXAI)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exscientia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exscientia was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與ExScience a的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。ExScience a的上一次評級是在2023年10月17日提交的，所以你應該預計下一次評級將在2024年10月17日左右提供。
Is the Analyst Rating Exscientia (EXAI) correct?
分析師評級ExScience a(EXAI)正確嗎？
While ratings are subjective and will change, the latest Exscientia (EXAI) rating was a maintained with a price target of $12.00 to $10.00. The current price Exscientia (EXAI) is trading at is $5.80, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的ExScience a(EXAI)評級維持不變，目標價在12.00美元至10.00美元之間。目前ExScience a(EXAI)的交易價格為5.8美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。